<SEC-DOCUMENT>0001193125-23-196279.txt : 20230727
<SEC-HEADER>0001193125-23-196279.hdr.sgml : 20230727
<ACCEPTANCE-DATETIME>20230727172702
ACCESSION NUMBER:		0001193125-23-196279
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20230726
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230727
DATE AS OF CHANGE:		20230727

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MEI Pharma, Inc.
		CENTRAL INDEX KEY:			0001262104
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				510407811
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-50484
		FILM NUMBER:		231119503

	BUSINESS ADDRESS:	
		STREET 1:		11455 EL CAMINO REAL
		STREET 2:		SUITE 250
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130
		BUSINESS PHONE:		858-369-7100

	MAIL ADDRESS:	
		STREET 1:		11455 EL CAMINO REAL
		STREET 2:		SUITE 250
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MARSHALL EDWARDS INC
		DATE OF NAME CHANGE:	20030902
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d540602d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:meip="http://www.meipharma.com/20230726" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2023-07-26_to_2023-07-26">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2023-07-26_to_2023-07-26">0001262104</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="meip-20230726.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2023-07-26_to_2023-07-26"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001262104</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-07-26</xbrli:startDate> <xbrli:endDate>2023-07-26</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2023-07-26_to_2023-07-26">8-K</ix:nonNumeric></span></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(D)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2023-07-26_to_2023-07-26" format="ixt:datemonthdayyearen">July&#160;26, 2023</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of report (Date of earliest event reported)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2023-07-26_to_2023-07-26">MEI Pharma, Inc.</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2023-07-26_to_2023-07-26" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2023-07-26_to_2023-07-26">000-50484</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2023-07-26_to_2023-07-26">51-0407811</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:48%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2023-07-26_to_2023-07-26">11455 El Camino Real</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="duration_2023-07-26_to_2023-07-26">Suite 250</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2023-07-26_to_2023-07-26">San Diego</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2023-07-26_to_2023-07-26" format="ixt-sec:stateprovnameen">California</ix:nonNumeric></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2023-07-26_to_2023-07-26">92130</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of principal executive offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2023-07-26_to_2023-07-26">(858)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2023-07-26_to_2023-07-26">369-7100</ix:nonNumeric></span></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2023-07-26_to_2023-07-26" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2023-07-26_to_2023-07-26" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2023-07-26_to_2023-07-26" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2023-07-26_to_2023-07-26" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of Each Class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br />Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2023-07-26_to_2023-07-26">Common stock, $0.00000002 par value</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2023-07-26_to_2023-07-26">MEIP</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2023-07-26_to_2023-07-26" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter)</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&#160;&#160;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2023-07-26_to_2023-07-26" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;&#9744;</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;5.02</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Departure of Directors or Certain Officer; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Appointment of Mr.&#160;Justin J. File as Chief Financial Officer </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As previously disclosed and incorporated herein by reference to MEI Pharma, Inc.&#8217;s (the &#8220;Company&#8221;) Current Report on Form <span style="white-space:nowrap">8-K,</span> filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on June&#160;13, 2023 (File <span style="white-space:nowrap">No.&#160;000-50484),</span> the Board of Directors (the &#8220;Board&#8221;) of the Company previously determined that it was appropriate to appoint Justin J. File as Chief Financial Officer (&#8220;CFO&#8221;) of the Company no later than September&#160;1, 2023, at which time Mr.&#160;File would cease to serve as Executive Vice President of Finance. On July&#160;26, 2023, the Board has appointed Mr.&#160;File as CFO and Corporate Secretary, effective as of August&#160;1, 2023 (the &#8220;Transition Date&#8221;). </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Termination of Mr.&#160;Brian Drazba </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As previously disclosed, the Board determined that Brian G. Drazba&#8217;s employment as CFO of the Company would terminate no later than September&#160;1, 2023. On July&#160;26, 2023, the Board determined that Mr.&#160;Drazba&#8217;s employment as CFO shall terminate without cause, effective as of the Transition Date, under the terms of the Separation and Release Agreement, dated June&#160;16, 2023. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As previously disclosed and incorporated herein by reference to the Company&#8217;s Current Report on Form <span style="white-space:nowrap">8-K,</span> filed with the SEC on June&#160;13, 2023 (File <span style="white-space:nowrap">No.&#160;000-50484),</span> Mr.&#160;Drazba will receive severance and other benefits if he signs and does not revoke the Separation and Release Agreement, and he remains in compliance with the terms of his Employee Proprietary Information and Inventions Agreement, dated April&#160;3, 2017. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The full text of the Drazba Separation and Release Agreement is attached as Exhibit 10.1 to this Current Report on Form <span style="white-space:nowrap">8-K</span> and is incorporated herein by reference. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following exhibits are being filed as part of this Current Report on Form <span style="white-space:nowrap">8-K.</span> </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:5%"></td>
<td style="width:92%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Exhibit<br />Number</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d540602dex101.htm">Separation and Release Agreement between the Company and Brian Drazba, dated June&#160;16, 2023 </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:44%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:5%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:44%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom" colspan="3">Date: July&#160;27, 2023</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3">MEI Pharma, Inc.</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ <span style="font-style:italic">David M. Urso</span></p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Name:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">David M. Urso</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Title:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Chief Executive Officer</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>d540602dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Separation and Release Agreement </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Separation and Release Agreement (&#147;<B>Agreement</B>&#148;) is made between you, Brian G. Drazba, and MEI Pharma, Inc., and sets forth the terms of
your separation from employment with MEI Pharma, Inc. and its affiliates (&#147;<B>MEI</B>&#148;). This Agreement will become effective upon the &#147;<B>Effective Date</B>&#148; as specified in Section&nbsp;11(a), below. Once effective, this
Agreement will be a legally binding document representing the entire agreement between you and MEI regarding the subjects it covers. Throughout this Agreement, the term the &#147;<B>MEI</B>&#148; includes all of MEI&#146;s affiliates and related
entities, and their current and former trustees, officers, agents, employees, insurers and attorneys, and all other employee benefit plans and arrangements and their administrators, trustees and other fiduciaries, and all successors and assigns of
all of the foregoing. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <B>Separation Date and Transition Period</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a) Separation Date</B>. Your employment with MEI will terminate effective as of the closing date of the Merger (as defined below), and in
any event no later than September&nbsp;1, 2023 (the &#147;<B>Designated Date</B>&#148;) as a termination by MEI other than for Cause under the employment agreement between you and MEI, dated February&nbsp;1, 2017 (the &#147;<B>Employment
Agreement</B>&#148;). For purposes of this Agreement the &#147;<B>Merger</B>&#148; refers to the merger between MEI, Infinity Pharmaceuticals, Inc. (&#147;<B>Infinity</B>&#148;), and Meadow Merger Sub, Inc., a wholly owned subsidiary of the MEI
(&#147;<B>Merger Sub</B>&#148;), whereby Merger Sub will merge with and into Infinity, with Infinity being the surviving entity as a wholly owned subsidiary of MEI, as entered into in the Agreement and Plan of Merger, dated February&nbsp;22, 2023.
Pursuant to Section&nbsp;1(b) below, you will remain employed through the Designated Date, unless terminated earlier by you or MEI. If MEI terminates your employment prior to the Designated Date (other than termination by MEI for Cause, as defined
in your Employment Agreement), MEI will provide thirty (30)&nbsp;days prior written notice of such termination. The date on which your employment terminates for any reason, including separation on the Designated Date, is referred to as the
&#147;<B>Separation Date</B>.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b) Transition</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(i) Transition Period; Duties</B>. Through the period ending on the Separation Date, you will continue to serve as Chief Financial Officer
(&#147;<B>CFO</B>&#148;) of MEI with the duties, responsibilities and authority consistent with your duties as in effect immediately prior to the Effective Date; provided, that such duties will also include assisting in the orderly transition of
your responsibilities as CFO and performing such other duties as may be reasonably assigned by the Chief Executive Officer of MEI. By signing this Agreement, you agree to perform these duties and responsibilities to the best of your abilities, in a
diligent, trustworthy, professional, and efficient manner, and to comply with MEI&#146;s policies and procedures in all material respects. The period from the Effective Date through the Separation Date is referred to as the &#147;<B>Transition
Period</B>.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(ii) Compensation and Benefits</B>. During the Transition Period, you will continue to receive your base salary at
the rate in effect as of the Effective Date of this Agreement, and you will continue to be eligible to participate in the benefit plans that MEI makes generally available to its employees, subject to the terms and conditions of those plans. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <B>Consideration and Post-Transition Benefits and Payments</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a) Eligibility</B>. Provided that you (i)&nbsp;separate from employment on the Separation Date other than for Cause or your voluntary
termination before the Designated Date, (ii)&nbsp;sign and do not revoke this Agreement, including the waiver and release of claims in favor of MEI and the restrictive </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
covenants contained in it, within <FONT STYLE="white-space:nowrap">twenty-one</FONT> (21)&nbsp;days of receiving this Agreement, (iii)&nbsp;again sign and do not revoke this Agreement upon or
within <FONT STYLE="white-space:nowrap">twenty-one</FONT> (21)&nbsp;days after the Separation Date, and (iv)&nbsp;remain in compliance with the terms of this Agreement and your continuing obligations under your Employment Agreement and your Employee
Proprietary Information and Inventions Agreement dated April&nbsp;3, 2017 (&#147;<B>Proprietary Information Agreement</B>&#148;), MEI agrees to provide you with the payments and benefits set forth in Section&nbsp;2(b) below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b) Consideration</B>. Subject to satisfying the eligibility criteria in Section&nbsp;2(a), above, MEI agrees to provide you with the
following payments and benefits (collectively referred to as the &#147;<B>Separation Benefits</B>&#148;): </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(i) Severance Payment</B>.
MEI will pay you a lump sum payment of $428,634.96, which is equal to twelve (12)&nbsp;months of your annual base salary, as soon as administratively practicable after the Separation Date (but not later than sixty (60)&nbsp;days after the Separation
Date). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(ii) COBRA Reimbursement</B>. Subject to your timely election of health care continuation coverage under COBRA, MEI will pay
the monthly premium payable to continue your and your eligible dependents&#146; participation in the MEI&#146;s group health plan (to the extent permitted under applicable law and the terms of such plan) which covers you (and your eligible
dependents) for a period of twelve (12)&nbsp;months; provided that you are eligible and remain eligible for COBRA coverage; and further provided that in the event you obtain other employment that offers group health benefits, such continuation of
coverage by MEI will immediately cease. If the reimbursement of any COBRA premiums would violate the nondiscrimination rules or cause the reimbursement to be taxable under the Patient Protection and Affordable Care Act of 2010, together with the
Health Care and Education Reconciliation Act of 2010 or Section&nbsp;105(h) of the Internal Revenue Code of 1986, as amended (the &#147;<B>Code</B>&#148;), this arrangement will be modified to effect a lump sum payment to you of the payment amount
described above reduced by applicable withholding taxes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(iii) 2023 Annual Bonus</B>. MEI may pay you an annual bonus for the fiscal
year ending June&nbsp;30, 2023, based on attainment of performance goals established by the Board of Directors of MEI (the &#147;<B>Board</B>&#148;) for the year and the Board&#146;s discretion, consistent with MEI&#146;s Discretionary Annual Bonus
Policy (except that you are not required to be employed by MEI through the payment date for the bonus) (the &#147;<B>2023 Bonus</B>&#148;). The 2023 Bonus will be paid when 2023 fiscal year annual bonuses are paid to MEI employees. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>(iv) Stock Option Accelerated Vesting and Exercise Period</B>. Your outstanding options to purchase MEI common stock shall vest and become
exercisable on an accelerated basis as of the Separation Date for the same number of shares that would have vested had you continued to be employed by MEI through the first (1st) anniversary of the Separation Date. All other unvested stock options
shall terminate and be forfeited as of the Separation Date. You may exercise your vested stock options through the first (1st) anniversary of the Separation Date, or until the expiration of the term, if earlier, subject to the terms of the
applicable option agreements (other than the ninety (90)&nbsp;day post-termination exercise period, which shall not apply). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(c)
Termination for Cause</B>. If MEI terminates your employment for Cause prior to the Separation Date, or if you voluntarily terminate employment before the Designated Date, your employment with MEI will end as of such date, and you will only be
eligible to receive the payments and benefits set forth in Section&nbsp;2(d). For the avoidance of doubt, you will not be eligible to receive any of the Separation Benefits. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(d) Other Payments</B>. Regardless of whether you sign this Agreement or when or why your
employment with MEI terminates, MEI will provide you with any earned but unpaid base salary through the Separation Date, reimbursement for any outstanding expenses for which you have not been reimbursed and which are authorized, any accrued but
unused vacation, and any vested benefits under MEI&#146;s employee benefit plans in accordance with the terms of such plans, as accrued through the Separation Date.&nbsp;&nbsp;&nbsp;&nbsp; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(e) Benefits Termination</B>. For purposes of any benefits provided under any MEI benefits plan, your employment will terminate on the
Separation Date, and benefits will cease on the Separation Date, consistent with the terms of the applicable benefit plans. You will receive information, under separate cover, regarding your rights under the COBRA health coverage continuation
provisions of applicable law, as well as time frames necessary for continuations, conversions and/or distribution of benefits under MEI&#146;s benefit programs after your employment terminates. MEI reserves the right, in its sole discretion, to
change or discontinue its benefit plans at any time, with or without prior notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <B>Release of Claims</B>. In exchange for the
benefits provided under this Agreement and other valuable consideration, you hereby waive, to the fullest extent permitted by law, all claims available under federal, state or local law against MEI and the trustees, officers, employees, and agents
of MEI, including but not limited to all claims arising out of your employment with MEI or the termination of that employment, and all claims arising under the Employment Agreement, or arising under the Age Discrimination in Employment Act of 1967
(&#147;<B>ADEA</B>&#148;), the Older Workers Benefit Protection Act, the Americans with Disabilities Act, the Civil Rights Act of 1991, the Rehabilitation Act of 1973, the Employee Retirement Income Security Act of 1974, the Worker Adjustment and
Retraining Notification Act, the Uniformed Services Employment and Reemployment Rights Act, the Employee Separation Income Security Act, the Equal Pay Act, the Genetic Information <FONT STYLE="white-space:nowrap">Non-discrimination</FONT> Act, the
Family and Medical Leave Act, Section&nbsp;1981 of U.S.C., Title VII of the Civil Rights Act of 1964, as amended, the Fair Labor Standards Act, California&#146;s Fair Employment and Housing Act, the Unruh Civil Rights Act, the California Business
and Professions Code, California Equal Pay Law, California Whistleblower Protection Laws, California Family Rights Act, California Pregnancy Disability Leave Law, California Paid Sick Days, California Labor Code, California WARN law, any applicable
California Industrial Welfare Commission Wage Order, wrongful termination in violation of public policy (<I>Tameny</I> claims), the California Constitution or any common law, as well as any claims arising under any federal, state or local fair
employment practices statutes, regulations, or ordinances, wrongful termination claims, breach of contract claims, discrimination claims, harassment claims, retaliation claims, claims for unpaid wages or other compensation, whistleblower claims (to
the fullest extent they may be released under applicable law), defamation or other tort claims, and claims for attorneys&#146; fees and costs. Notwithstanding the foregoing general releases, you acknowledge that you have not made any claims or
allegations related to sexual harassment or sexual abuse, and none of the payments set forth as consideration in this Agreement are related to sexual harassment or sexual abuse. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You specifically acknowledge that you are aware of and familiar with the provisions of CALIFORNIA CIVIL CODE SECTION 1542, which provides as follows: A
GENERAL RELEASE DOES NOT EXTEND TO CLAIMS THAT THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE AND THAT, IF KNOWN BY HIM OR HER, WOULD HAVE MATERIALLY AFFECTED HIS OR HER
SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the purpose of implementing a full and complete release, you hereby expressly waive all rights and
benefits you may have under this section, as well as under any other statutes or common law principle of similar effect which provides any remedy of any kind, and acknowledge that the release set forth in this Agreement is intended to include the
discharge of all claims which you do not know or suspect to exist at the time this Agreement is effective. You agree and acknowledge that this is a knowing and voluntary waiver. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You understand and acknowledge that you are waiving and releasing any rights you may have under the ADEA, and that this waiver and release is knowing and
voluntary. You understand and agree that this waiver and release does not apply to any rights or claims that may arise under the ADEA after the Effective Date of this Agreement. You understand and acknowledge that the consideration given for this
waiver and release is in addition to anything of value to which you were already entitled. You further understand and acknowledge that you have been advised by this writing that: (a)&nbsp;you should consult with an attorney prior to executing this
Agreement; (b)&nbsp;you have the periods described in Section&nbsp;10 below to sign and revoke this Agreement. In the event you sign this Agreement and return it to MEI in less than the <FONT STYLE="white-space:nowrap">twenty-one</FONT>
(21)&nbsp;day periods identified below, you hereby acknowledge that you have freely and voluntarily chosen to waive the time period allotted for considering this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, you are not waiving your right to (i)&nbsp;any vested benefits under a MEI benefit plan, the rights to which are governed by
the terms of the applicable plan documents and/or award agreement, (ii)&nbsp;claims for unemployment or workers&#146; compensation benefits, (iii)&nbsp;any medical claim incurred during your employment that is payable under applicable medical plans
or a <FONT STYLE="white-space:nowrap">MEI-insured</FONT> liability plan, (iv)&nbsp;claims arising after the date on which you sign this Agreement, (v)&nbsp;any rights to indemnification and defense under MEI&#146;s bylaws and under directors and
officers insurance with respect to your service as an employee or officer of MEI, or (vi)&nbsp;claims that are not otherwise waivable under applicable law.&nbsp;&nbsp;&nbsp;&nbsp; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <B>Continuing Obligations</B>. You agree that you remain bound by any prior restrictive covenant agreements between you and MEI, including
without limitation the Proprietary Information Agreement. In addition: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a) Limits on Adverse Comments</B>. Except as provided in
Section&nbsp;6 below, you agree that you will not make or authorize any written or oral statements that are false, disparaging or defamatory about MEI or its affiliates or their respective directors, officers or employees.&nbsp;&nbsp;&nbsp;&nbsp;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b) Duty of Cooperation</B>. You agree to reasonably cooperate with MEI and its counsel after the Separation Date with respect to any
matter (including any litigation, investigation, or governmental proceeding) which relates to your employment with MEI. This cooperation may include appearing from
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">time-to-time</FONT></FONT> for conferences and interviews at mutually agreeable times and providing the officers of MEI and its counsel with the full benefit of your knowledge with
respect to any such matter. MEI agrees to reimburse you for any reasonable <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses incurred by you in connection with such cooperation and mutually agreed
upon in advance by you and MEI. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <B>Return of Records and Equipment</B>. On or before your Separation Date, you will return to MEI all
documents, manuals, office equipment, credit cards and other things belonging to MEI which you have borrowed or which you possess or control. To the extent that you have made use of your own personal computing devices (e.g., PDA, laptop, thumbdrive,
etc.) during employment with MEI, you agree to delete all MEI property and information from such personal computing devices, and/or permit MEI to remotely delete all MEI property and information from such personal computing devices. You authorize
MEI to deduct from your paycheck or amounts paid under this Agreement any money owed MEI as a result </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of items which are not returned or for loans or advances you have received and which remain unpaid, if you agreed to allow such deductions at the time the loans or advances were made. The
obligations described in this Section&nbsp;5 are in addition to your obligations to return Company documents and other property as set forth in the Proprietary Information Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <B>Reports to Government Entities</B>. Nothing in this Agreement restricts or prohibits you from initiating communications directly with,
responding to any inquiries from, providing testimony before, providing confidential information to, reporting possible violations of law or regulation to, or from filing a claim or assisting with an investigation directly with a self-regulatory
authority or a government agency or entity, including without limitation the Equal Employment Opportunity Commission, or from making other disclosures that are protected under the whistleblower provisions of state or federal law or regulation.
However, you are waiving your right to receive any individual monetary relief from MEI or any others covered by the Release of Claims, provided for in Section&nbsp;3 of this Agreement, resulting from such claims, regardless of whether you or another
party has filed them, and in the event you obtain such monetary relief, MEI will be entitled to an offset for the payments made pursuant to this Agreement, except where such limitations are prohibited as a matter of law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Please take notice that federal law provides criminal and civil immunity to federal and state claims for trade secret misappropriation to individuals who
disclose a trade secret to their attorney, a court, or a government official in certain, confidential circumstances that are set forth at 18 U.S.C. &#167;&#167; 1833(b)(1) and 1833(b)(2), related to the reporting or investigation of a suspected
violation of the law, or in connection with a lawsuit for retaliation for reporting a suspected violation of the law.&nbsp;&nbsp;&nbsp;&nbsp; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <B>No Other Amounts Due</B>. You agree and represent that other than as provided for in this Agreement, you have received all entitlements
due from MEI relating to your employment with MEI or under your Employment Agreement, including but not limited to, all wages earned, including without limitation all commissions and bonuses, sick pay, vacation pay, overtime pay, and any paid and
unpaid personal leave for which you were eligible and entitled, and that MEI has no obligation to pay any additional amounts, other than the payments and benefits described herein. Except as expressly provided for herein, your Employment Agreement
with MEI is hereby terminated. You further acknowledge that the payments and benefits provided under this Agreement fully satisfy MEI&#146;s obligations to provide benefits under the Employment Agreement and any other MEI benefit plan which could
provide severance or other similar benefits. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <B>Notices</B>. Notices and all other communications provided for in this Agreement shall
be delivered (a)&nbsp;to you, at the last address maintained in MEI&#146;s records, and (b)&nbsp;to MEI, by delivering such notice or communications to the individual and at the address, including <FONT STYLE="white-space:nowrap">e-mail</FONT>
address, set forth below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">MEI Pharma, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11455 El Camino Real, Suite 250 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">San Diego, CA 92130 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Atten: VP
Legal and Compliance </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <B>Medicare Disclaimer</B>. You represent that you are not a Medicare Beneficiary as of the time you enter into
this Agreement. To the extent that you are a Medicare Beneficiary, you agree to notify MEI in accordance with the notice provisions set forth in Section&nbsp;8, above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <B>Acknowledgement of Voluntariness and Time to</B> Review. You acknowledge that: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) You have read this Agreement and you understand it; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b) </B>You are signing this Agreement voluntarily, without any duress or undue influence
on the part or behalf of MEI or any third party, in order to release your claims against MEI in exchange for the Separation Benefits, which, in the aggregate, are greater than you would have otherwise received; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> You are signing this Agreement twice: the first time, within <FONT STYLE="white-space:nowrap">twenty-one</FONT> (21)&nbsp;days of
receiving it; and the second time, upon or within <FONT STYLE="white-space:nowrap">twenty-one</FONT> (21)&nbsp;days after the Separation Date; <B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(d)</B><B></B> You were offered at least <FONT STYLE="white-space:nowrap">twenty-one</FONT> (21)&nbsp;days to consider your choice to sign
this Agreement both times, and to the extent you executed this Agreement before the expiration of the <FONT STYLE="white-space:nowrap">twenty-one</FONT> (21)&nbsp;days, you have done so voluntarily and knowingly without any inducement by MEI through
fraud, misrepresentation, or a threat to withdraw or alter the offer prior to the expiration of the <FONT STYLE="white-space:nowrap">twenty-one</FONT> (21)&nbsp;day period; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(e)</B><B></B> MEI advises you to consult with an attorney, and you were provided no less than five (5)&nbsp;business days to retain such
counsel; <B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(f)</B><B></B> You know that you can revoke this Agreement within seven (7)&nbsp;days of signing it and that the
Agreement does not become effective until that seven <FONT STYLE="white-space:nowrap">(7)-day</FONT> period has passed; <B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(g)</B><B></B> If you sign and do not revoke this Agreement within <FONT STYLE="white-space:nowrap">twenty-one</FONT> (21)&nbsp;days of
receiving it, and then you do not reaffirm the Agreement (or you revoke the reaffirmation) upon or after the Separation Date, the Agreement will remain in effect except that MEI will not be obligated to pay you the Separation
Benefits;&nbsp;&nbsp;&nbsp;&nbsp;<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(h) </B>To revoke this Agreement, you agree to notify MEI in accordance with the notice
provisions set forth in Section&nbsp;8 above; <B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(i)</B><B></B> You agree that changes to this Agreement before its execution,
whether material or immaterial, do not restart your time to review the Agreement; <B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(j)</B><B></B> You acknowledge that nothing
in this Agreement is an admission of any wrongdoing, liability, or unlawful activity by you or by MEI; <B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(k)</B><B></B> This is
a negotiated agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(l)</B><B></B> Your agreement is voluntary, deliberate, and informed; and <B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(m)</B><B></B> The Agreement provides consideration of value to you. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. <B>Effective Date</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a) Effective Date</B>. This Agreement will become effective and enforceable upon the expiration of the seven (7)&nbsp;business day
revocation period provided for in Section&nbsp;10(f), above with respect to your first signing the Agreement (the &#147;<B>Effective Date</B>&#148;). If you fail to return an executed original to MEI in accordance with the notice provisions set
forth in Section&nbsp;8 above, within <FONT STYLE="white-space:nowrap">twenty-one</FONT> (21)&nbsp;days after you receive this Agreement, then this Agreement, including but not limited to the obligation of MEI to provide the Separation Benefits,
shall be deemed automatically null and void. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b) Revocation Period</B>. When you sign this Agreement the first time, the Agreement
becomes effective immediately after the seven (7)&nbsp;day revocation period following that signature, if you do not revoke the Agreement. When you sign this Agreement the second time, your second signature becomes effective immediately after the
seven (7)&nbsp;day revocation period following that second signature, if you do not revoke the Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12. <B>Section</B><B></B><B>&nbsp;409A. </B>This Agreement is intended to comply with the
requirements of Section 409A of the Code (&#147;<B>Section</B><B></B><B>&nbsp;409A</B>&#148;) or an exception, and shall be administered accordingly. Notwithstanding anything in the Agreement to the contrary, distributions may only be made under the
Agreement upon an event and in a manner permitted by Section&nbsp;409A or an applicable exemption. Payments to be made upon termination of employment under this Agreement may only be made upon a &#147;separation from service&#148; under
Section&nbsp;409A. For purposes of Section&nbsp;409A, each payment shall be treated as a separate payment. In no event may you, directly or indirectly, designate the calendar year of a payment.<B> </B>MEI makes no representation or warranty with
respect to tax consequences of this Agreement, and MEI shall have no liability to you or any other person for any taxes or penalties imposed pursuant to Section&nbsp;409A.<B> </B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13. <B>Entire Agreement</B>. This Agreement contains the full agreement between you and MEI and completely supersedes any prior written or
oral agreements or representations concerning the subject matter thereof (including, but not limited to, the Employment Agreement), other than the Proprietary Information Agreement. Any oral representation or modification concerning this Agreement
shall be of no force or effect. You and MEI may extend the term of this Agreement by a written amendment signed by both you and MEI. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.
<B>Severability</B>. In the event a court, arbitrator, or other entity with jurisdiction determines that any portion of this Agreement (other than the general release clause) is invalid or unenforceable, the remaining portions of the Agreement shall
remain in full force and effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15. <B>Governing Law</B>. This Agreement shall be governed by and construed according to the laws of the
State of California, without reference to that jurisdiction&#146;s choice of law rules. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16. <B>Tax Withholding.</B> All payments under
this Agreement are subject to applicable tax withholding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17. <B>Signature</B>. If you choose to accept this Agreement, please sign the
Agreement, and return this Agreement to MEI in accordance with the notice provisions set forth in Section&nbsp;8 above, no later than <FONT STYLE="white-space:nowrap">twenty-one</FONT> (21)&nbsp;days after you receive this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page Follows.] </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I agree to all terms of the Agreement as of the date of this signature. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>(To Be Signed Within <FONT STYLE="white-space:nowrap">Twenty-One</FONT> (21)&nbsp;Days of Receiving This Agreement) </I></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="44%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Brian G. Drazba</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>MEI Pharma, Inc.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Brian G. Drazba</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ David Urso</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: June&nbsp;16, 2023 | 12:07 PM PDT</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">David Urso</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">President&nbsp;&amp; CEO</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">June&nbsp;20, 2023 | 12:14 PM PDT</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I hereby reaffirm the terms of the Agreement. I agree to all terms of the Agreement as of the date of this signature. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>(To Be Signed Within <FONT STYLE="white-space:nowrap">Twenty-One</FONT> (21)&nbsp;Days of the Separation Date) </I></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="44%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Brian G. Drazba</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>MEI Pharma, Inc.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2023</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">David Urso</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">President&nbsp;&amp; Chief Executive Officer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2023</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Brian Drazba Separation and Release Agreement</I>] </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>meip-20230726.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 7/28/2023 1:21:00 AM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2022"
  xmlns:meip="http://www.meipharma.com/20230726"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.meipharma.com/20230726"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" namespace="http://xbrl.sec.gov/naics/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="meip-20230726_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="meip-20230726_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.meipharma.com//20230726/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>meip-20230726_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 7/28/2023 1:21:00 AM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>meip-20230726_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 7/28/2023 1:21:00 AM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.meipharma.com//20230726/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="meip-20230726.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.meipharma.com//20230726/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140204323113328">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jul. 26, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001262104<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul. 26,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">MEI Pharma, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-50484<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">51-0407811<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">11455 El Camino Real<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92130<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(858)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">369-7100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common stock, $0.00000002 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MEIP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>d540602d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="meip-20230726.xsd" xlink:type="simple"/>
    <context id="duration_2023-07-26_to_2023-07-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001262104</identifier>
        </entity>
        <period>
            <startDate>2023-07-26</startDate>
            <endDate>2023-07-26</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2023-07-26_to_2023-07-26">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2023-07-26_to_2023-07-26"
      id="Hidden_dei_EntityCentralIndexKey">0001262104</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2023-07-26_to_2023-07-26">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2023-07-26_to_2023-07-26">2023-07-26</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2023-07-26_to_2023-07-26">MEI Pharma, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2023-07-26_to_2023-07-26">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2023-07-26_to_2023-07-26">000-50484</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2023-07-26_to_2023-07-26">51-0407811</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2023-07-26_to_2023-07-26">11455 El Camino Real</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2023-07-26_to_2023-07-26">Suite 250</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="duration_2023-07-26_to_2023-07-26">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2023-07-26_to_2023-07-26">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2023-07-26_to_2023-07-26">92130</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2023-07-26_to_2023-07-26">(858)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2023-07-26_to_2023-07-26">369-7100</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2023-07-26_to_2023-07-26">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2023-07-26_to_2023-07-26">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2023-07-26_to_2023-07-26">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2023-07-26_to_2023-07-26">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2023-07-26_to_2023-07-26">Common stock, $0.00000002 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2023-07-26_to_2023-07-26">MEIP</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2023-07-26_to_2023-07-26">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2023-07-26_to_2023-07-26">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=>Y!L/?P&HT=S8\?M_P!4$L#!!0    ( &"+^U8D'INBK0   /@!   :
M>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'.UD3T.@S ,A:\2Y0 U4*E#!4Q=
M6"LN$ 7S(Q(2Q:X*MR^% 9 Z=&&RGBU_[\E.GV@4=VZ@MO,D1FL&RF3+[.\
MI%NTBB[.XS!/:A>LXEF&!KS2O6H0DBBZ0=@S9)[NF:*<//Y#='7=:7PX_;(X
M\ \PO%WHJ45D*4H5&N1,PFBV-L%2XLM,EJ*H,AF**I9P6B#BR2!M:59]L$].
MM.=Y%S?W1:[-XPFNWPQP>'3^ 5!+ P04    " !@B_M699!YDAD!  #/ P
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M<' N>&UL4$L! A0#%     @ 8(O[5FC_=W;N    *P(  !$
M ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ 8(O[5IE<G",0
M!@  G"<  !,              ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q0
M2P$"% ,4    " !@B_M6S]MK+5P$   I$0  &               @($-"
M>&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ 8(O[5I^@&_"Q
M @  X@P   T              ( !GPP  'AL+W-T>6QE<RYX;6Q02P$"% ,4
M    " !@B_M6EXJ[',     3 @  "P              @ %[#P  7W)E;',O
M+G)E;'-02P$"% ,4    " !@B_M6'#AEZC\!   \ @  #P
M@ %D$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ 8(O[5B0>FZ*M
M^ $  !H              ( !T!$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR
M96QS4$L! A0#%     @ 8(O[5F60>9(9 0  SP,  !,              ( !
MM1(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  _Q,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d540602d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.meipharma.com//20230726/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d540602d8k.htm">d540602d8k.htm</File>
    <File>d540602dex101.htm</File>
    <File>meip-20230726.xsd</File>
    <File>meip-20230726_lab.xml</File>
    <File>meip-20230726_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d540602d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 23
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d540602d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "meip-20230726_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "meip-20230726_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "meip-20230726.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "meip",
   "nsuri": "http://www.meipharma.com/20230726",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d540602d8k.htm",
      "contextRef": "duration_2023-07-26_to_2023-07-26",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.meipharma.com//20230726/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d540602d8k.htm",
      "contextRef": "duration_2023-07-26_to_2023-07-26",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.meipharma.com//20230726/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.meipharma.com//20230726/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.meipharma.com//20230726/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.meipharma.com//20230726/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.meipharma.com//20230726/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.meipharma.com//20230726/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.meipharma.com//20230726/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.meipharma.com//20230726/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.meipharma.com//20230726/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.meipharma.com//20230726/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.meipharma.com//20230726/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.meipharma.com//20230726/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.meipharma.com//20230726/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.meipharma.com//20230726/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.meipharma.com//20230726/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.meipharma.com//20230726/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.meipharma.com//20230726/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.meipharma.com//20230726/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.meipharma.com//20230726/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.meipharma.com//20230726/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.meipharma.com//20230726/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.meipharma.com//20230726/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.meipharma.com//20230726/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0001193125-23-196279-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-23-196279-xbrl.zip
M4$L#!!0    ( &"+^U:3^%,$B1   *YM   .    9#4T,#8P,F0X:RYH=&WM
M7>MSXC@2_[Y5^S^HV-LK4A7 )N1%,KG*$&:/W<FC('NW=5^VA"V";HS%2G*
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M"5J3CER)2MD]?8'^N$?ZP'!17Q?ZAK!:]MO'YN=Q=SV__[AK24L:JHX #FA
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M.:UZ[==FX[%1;Y'KNQM2_ZWVS^N[G^JD=G][VVBU&O=WKZ*QO T:_TU5%^)
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MMVW_)"_NVVW+>//R^^_ J\P%)NO-X!)O98*6-@/)0] 2#.A(84 (@^/75M(
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MXW@IQE$21LE4A&E0TB.96F0JAW_AMP@@_C.#5^P@WI[8'<A@N"PTK^3E^'<
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M*8!*Q)$L@4&7@,N,C[U;_(U'OT/K#,4;-<Y*F2T]*+O/:U .[)@>4ZKPSC<
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M)"%A1B\%=$6>YT:&_G.,G#TR<H[P) *K<?MZGN;%MK>'9I_Y1TF".']0LV=
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M#F*QT+2.Z.M- +$A/7N$>] +"#J0I;L=&&NJ"&&.FQ\S=NA9?'\0E@%#=J$
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MX\+S]>->U]SM9F;4]E8)W%BQ.W]:K^7>+Z_ECSZQX98X(S94#3U<4-8>94\
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MS-!9:!(58%8N&C5AV6_/D&ZW*BG2=FD1.OLX-<@K:]5\??T>30!>;=?[P<X
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M9MMQW6U?L7Z.V>8@=S?#@6^OVH5#/_\'4$L#!!0    ( &"+^U8&,J)@>@8
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MV<(%90$+:1##;='Q*[AD81].XQ@^ZS2IVI1$W).HGZO&E/TWTG]-=?/P\@6
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M-@P/^6R]E'=<J2W]*U?R733[Q2-JS_]02P,$%     @ 8(O[5J]1^-/ !
M02P  !4   !M96EP+3(P,C,P-S(V7W!R92YX;6S5FEV/XC84AN]7VO_@IC>M
MU! 2=N<##;NBS$R%.E\"MJUZLS+) :PZ=F2' ?Y]CP-N"819F-U6\5P,D/@]
M?L]YC(F=7'U<IIP\@]),BHX7-IH> 1'+A(EIQYMKG^J8,8_HG(J$<BF@XZU
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M4$L! A0#%     @ 8(O[5A[#AMV*)P  ^J8  !$              ( !M1
M &0U-# V,#)D97@Q,#$N:'1M4$L! A0#%     @ 8(O[5E=4E"@_ P  3PL
M !$              ( !;C@  &UE:7 M,C R,S W,C8N>'-D4$L! A0#%
M  @ 8(O[5@8RHF!Z!@  N48  !4              ( !W#L  &UE:7 M,C R
M,S W,C9?;&%B+GAM;%!+ 0(4 Q0    ( &"+^U:O4?C3P 0  $$L   5
M          "  8E"  !M96EP+3(P,C,P-S(V7W!R92YX;6Q02P4&      4
,!0!  0  ?$<

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
